leisure time -WSS

leisure time

author：leisure time 2025-09-27 06:09:37 - browse：912

Anna Yeo/STAT

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case?

In utero gene editing, or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby preventing that entire protocol and the onset of symptoms in the first place. It would also challenge the need for the ethically fraught enterprise of embryo editing, as the treatment would only make edits in the DNA of the individual fetus — edits which would not be passed on in a heritable way.

Watch this video to learn more about in utero gene editing, how it works, and why scientists believe it might be an advantageous approach to treating certain genetic diseases.

Previous article： Medicare details structure of new drug price negotiation program
Next article： Covid silver lining: Unprecedented look at human immune system

focus

WSS

U.K. decision on ALS drug has neurologists, advocates up in arms

Oral obesity drug from Viking Therapeutics hits key early target

Readout Newsletter: What happened with Sarepta's Duchenne data

Paying for Covid pills will soon shift to insurers

Readout Newsletter: What happened with Sarepta's Duchenne data

FDA has safety concerns on CRISPR

hotspot

leisure time

focus

Medicare proposal to cover medical devices draws a mixed reaction

Florida Supreme Court upholds state's abortion ban

After affirmative action ruling, medical educators look to 'holistic review'

Oral obesity drug from Viking Therapeutics hits key early target

DIEP, the 'gold standard' of breast reconstruction, is under threat

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Medical records are filled with copy

First Opinion on colorectal cancer screening: letter and response

Activists slam private health insurers over coverage restrictions

Bird flu reported in person exposed to presumably infected cattle

focus

Readout Newsletter: What happened with Sarepta's Duchenne data

Traditional Chinese medicine benefits explored in new JAMA study

Emergency medicine has repudiated 'excited delirium.' Now what?

Senate panel to vote on hospitals, PBMs, prisoner care

Emergency medicine has repudiated 'excited delirium.' Now what?

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

knowledge

entertainment

focus

focus